Beurer India introduces GL 22 blood glucose monitor

Beurer India, a subsidiary of Germany-based Beurer GmbH, has officially launched the GL 22 Blood Glucose Monitor, unveiled by cricket legend and Brand Ambassador Sourav Ganguly at a special event.

The GL 22 Blood Glucose Monitor, manufactured under Beurer’s “Make in India” initiative, combines German precision with advanced technology designed to meet local needs.

The device features comprehensive monitoring capabilities, including average readings for 7, 14, 30, and 90 days, offering crucial insights into blood glucose trends. These features closely align with HbA1c levels, a critical marker for long-term blood sugar control, ensuring users and healthcare providers can manage diabetes more effectively.

Sebastian Kebbe, COO and MD, Beurer GmbH, highlighted the company’s focus on innovation and accessibility, stating “The GL 22 Monitor embodies Beurer’s dedication to delivering high-quality, affordable solutions. By manufacturing under the ‘Make in India’ initiative, we’ve ensured the product is tailored to the needs of Indian consumers, combining world-class quality with affordability.”

The launch event in Jaipur served as the platform to introduce Beurer’s larger vision for the Indian market. The company plans to strengthen community outreach by collaborating with healthcare professionals and organisations to conduct health camps, provide training on diabetes care, and educate users on best practices for using health monitoring devices.

With a 100-year legacy in health technology, Beurer continues to set global benchmarks in innovation and quality. Its extensive product portfolio, which includes blood pressure monitors, nebulisers, therapy equipment, and wellness devices, reinforces its commitment to enhancing health and quality of life.